Publication

Sting inhibitors

Related publications (87)

Optimal regimes for algorithm-assisted human decision-making

We consider optimal regimes for algorithm-assisted human decision-making. Such regimes are decision functions of measured pre-treatment variables and, by leveraging natural treatment values, enjoy a superoptimality property whereby they are guaranteed to o ...

2024

Electronic transport in graphene with out-of-plane disorder

Oleg Yazyev, Yifei Guan

Real-world samples of graphene often exhibit various types of out-of-plane disorder-ripples, wrinkles and folds-introduced at the stage of growth and transfer processes. These complex out-of-plane defects resulting from the interplay between self-adhesion ...

Berlin2024

MRI characterization of in vitro clots at 3T and 7T: A technical note

Lijing Xin, François Lazeyras

In acute ischemic stroke, the composition of the occlusive clot can be associated with the underlying pathophysiology and the response to treatment. For these reasons, it is important to characterize the clot composition from clinical scans. We examine the ...

Moulineaux Cedex 92024

Antiviral compounds, compositions and uses thereof

Francesco Stellacci, Matteo Gasbarri, Yong Zhu

Compounds, compositions and methods that can be used for the treatment of viral diseases are provided. ...

2023

Periodate activation with copper oxide nanomaterials for the degradation of ciprofloxacin- A new insight into the efficiency and mechanisms

Shaoxian Li, Xi Zhang

In this study, CuO was synthesized using a facile precipitation method and was characterized using various techniques for the efficient activation of periodate (PI). Compared to systems consisting of PI alone (0.5 mM) and CuO alone (0.5 g/L), the CuO (0.5 ...

ELSEVIER SCI LTD2023

Predicting changes in depression using person-generated health data

Mariko Makhmutova

Depression is a leading cause of disability, impacting the lives of an increasingly large number of individuals worldwide. Despite a range of treatment options, a substantial fraction of individuals experiencing depressive symptoms do not seek or receive t ...

2021

Treatment and prevention of aging related-disease and/or aging by the inhibition of sphingolipids

Johan Auwerx, Pirkka-Pekka Untamo Laurila

The present invention relates to an inhibitor of sphingolipids for use in the treatment or prevention of an aging related-disease and/or aging. ...

2021

Disorder‐Induced Signal Filtering with Topological Metamaterials

Romain Christophe Rémy Fleury, Farzad Zangeneh Nejad

Disorder, ubiquitously present in realistic structures, is generally thought to disturb the performance of analog wave devices, as it often causes strong multiple scattering effects that largely arrest wave transportation. Contrary to this general view, he ...

2020

Multidisciplinary Approach to Treat Erectile Dysfunction

Mikaël Nils Sturny

Erectile dysfunction (ED) is a widespread disease affecting approximately 20% of men. With a rising incidence due to the global ageing of the world population, it is estimated that over 322 million patients will be affected in 2025. While not being a lifet ...

EPFL2020

Lactate enhancing compounds and uses thereof

Pierre Magistretti, Sylvain Eric Lengacher, Charles Léonard Finsterwald

Abstract of the invention: The present invention relates to new agents useful for stimulating release of lactate by astrocytes. The invention further relates to methods of preparation, formulations and therapeutic uses of those agents, notably for the prev ...

2020

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.